Maarten F. Jebbink
YOU?
Author Swipe
View article: Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections
Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections Open
After 3 years of its introduction to humans, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been declared as endemic. Little is known about the severity of the disease manifestation that future infections may cause, espec…
View article: Diversity and Long-Term Dynamics of Human Blood Anelloviruses
Diversity and Long-Term Dynamics of Human Blood Anelloviruses Open
Knowledge of the persistence of AVs in humans is crucial to our understanding of the nature of AV infection (chronic or acute) and the role of AV in the host. We therefore investigated the dynamics of anellovirus infection in two healthy p…
View article: Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections Open
Human coronavirus HKU1 (HCoV-HKU1) is one of the four endemic coronaviruses. It has been suggested that there is a difference in incidence, with PCR-confirmed HCoV-NL63 and HCoV-OC43 infections occurring more commonly, whereas HCoV-HKU1 is…
View article: Early-Life Colonization by Anelloviruses in Infants
Early-Life Colonization by Anelloviruses in Infants Open
Anelloviruses (AVs) are found in the vast majority of the human population and are most probably part of a healthy virome. These viruses infect humans in the early stage of life, however, the characteristics of the first colonizing AVs are…
View article: Seasonal coronavirus protective immunity is short-lasting
Seasonal coronavirus protective immunity is short-lasting Open
View article: Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test Open
View article: Revolution in Evolution of Human “Anellome”
Revolution in Evolution of Human “Anellome” Open
Torque teno viruses (TTVs), the most well-known members of the family Anelloviridae, are not associated with any disease. They are one of the most abundant and divergent entities in the viral world; however, the cause of their varia…
View article: Coronavirus protective immunity is short-lasting
Coronavirus protective immunity is short-lasting Open
In the current COVID-19 pandemic a key unsolved question is the duration of acquired immunity in recovered individuals. The recent emergence of SARS-CoV-2 precludes a direct study on this virus, but the four seasonal human coronaviruses ma…
View article: Euclidean Distance Analysis Enables Nucleotide Skew Analysis in Viral Genomes
Euclidean Distance Analysis Enables Nucleotide Skew Analysis in Viral Genomes Open
Nucleotide skew analysis is a versatile method to study the nucleotide composition of RNA/DNA molecules, in particular to reveal characteristic sequence signatures. For instance, skew analysis of the nucleotide bias of several viral RNA ge…
View article: A Novel Astrovirus-Like RNA Virus Detected in Human Stool
A Novel Astrovirus-Like RNA Virus Detected in Human Stool Open
Several novel clades of astroviruses have recently been identified in human faecal samples. Here, we describe a novel astrovirus-like RNA virus detected in human stools, which we have tentatively named bastrovirus. The genome of this novel…
View article: Theoretical VIDISCA amplifiable fragments in human rRNA, and\n number of restriction sites.
Theoretical VIDISCA amplifiable fragments in human rRNA, and\n number of restriction sites. Open
aonly fragments larger than 50 nt and smaller than 600 nt are\n counted.
View article: Identification of a Novel Human Rhinovirus C Type by Antibody Capture VIDISCA-454
Identification of a Novel Human Rhinovirus C Type by Antibody Capture VIDISCA-454 Open
Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with …